Journal
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Volume 79, Issue 3, Pages 357-369Publisher
WILEY
DOI: 10.1111/bcp.12305
Keywords
clinical trials; ethics; medicines in children; paediatric drug therapy
Categories
Funding
- National Health and Medical Research Council
Ask authors/readers for more resources
Safety and efficacy data on many medicines used in children are surprisingly scarce. As a result children are sometimes given ineffective medicines or medicines with unknown harmful side effects. Better and more relevant clinical trials in children are needed to increase our knowledge of the effects of medicines and to prevent the delayed or non-use of beneficial therapies. Clinical trials provide reliable evidence of treatment effects by rigorous controlled testing of interventions on human subjects. Paediatric trials are more challenging to conduct than trials in adults because of the paucity of funding, uniqueness of children and particular ethical concerns. Although current regulations and initiatives are improving the scope, quantity and quality of trials in children, there are still deficiencies that need to be addressed to accelerate radically equitable access to evidence-based therapies in children.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available